Click on the logos for more information.
One of the top academic centers in the world, conducting a retrospective natural history study for CMT6, the C12orf65 (also referred to as MTRFR) gene.
The Willis Lab has developed a CMT4A rat model developed and owned by HNF to test a gene therapy to treat GDAP1, a recessive CMT4 subtype.
A premiere laboratory animal sourcer, has developed a rat model for two types of CMT - CMT4A-GDAP1 and SORD deficiency
The Burgess Mouse Laboratory is a state-of-the-art facility working to develop mouse models for Mito CMTs, including the MTRFR/C12orf65 gene to test repurposed drugs and gene therapies targeting the optic nerve and other phenotypes of disease.